THE EFFECTS OF PLATINUM-BASED CHEMOTHERAPY RECHALLENGE FOR ADVANCED UROTHELIAL CARCINOMA PATIENTS WHOSE DISEASE PROGRESSED AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY AND PEMBROLIZUMAB

被引：0
|
作者：
Yumioka, Tetsuya
Honda, Masashi
Shimizu, Ryutaro
Teraoka, Shogo
Kimura, Yusuke
Iwamoto, Hideto
Morizane, Shuichi
Hikita, Katsuya
Takenaka, Atsushi
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD55-11
引用
收藏
页码：E1001 / E1002
页数：2
相关论文
共 50 条
  • [1] Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
    Yumioka, Tetsuya
    Honda, Masashi
    Shimizu, Ryutaro
    Teraoka, Shogo
    Yamaguchi, Noriya
    Kawamoto, Bunya
    Iwamoto, Hideto
    Morizane, Shuichi
    Hikita, Katsuya
    Takenaka, Atsushi
    ANTICANCER RESEARCH, 2021, 41 (11) : 5767 - 5773
  • [2] Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
    Wong, Risa L.
    Ferris, Lorin A.
    Do, Olivia A.
    Holt, Sarah K.
    Ramos, Jorge D.
    Crabb, Simon J.
    Sternberg, Cora N.
    Bellmunt, Joaquim
    Ladoire, Sylvain
    De Giorgi, Ugo
    Harshman, Lauren C.
    Vaishampayan, Ulka N.
    Necchi, Andrea
    Srinivas, Sandy
    Pal, Sumanta K.
    Niegisch, Guenter
    Dorff, Tanya B.
    Galsky, Matthew D.
    Yu, Evan Y.
    ONCOLOGIST, 2021, : 1026 - 1034
  • [3] Impact of number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma.
    Necchi, Andrea
    Mariani, Luigi
    Lo Vullo, Salvatore
    Raggi, Daniele
    Giannatempo, Patrizia
    Bamias, Aristotelis
    Crabb, Simon J.
    Bellmunt, Joaquim
    Yu, Evan Y.
    Niegisch, Guenter
    Vaishampayan, Ulka N.
    Theodore, Christine
    Berthold, Dominik R.
    Srinivas, Sandy
    Sridhar, Srikala S.
    Plimack, Elizabeth R.
    Rosenberg, Jonathan E.
    Powles, Thomas
    Galsky, Matthew
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [4] Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma
    Furubayashi, Nobuki
    Hori, Yoshifumi
    Morokuma, Futoshi
    Tomoda, Toshihisa
    Negishi, Takahito
    Inoue, Tomohiro
    Kumagai, Masatoshi
    Kuroiwa, Kentaro
    Tokuda, Noriaki
    Nakamura, Motonobu
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (05)
  • [5] Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy
    Furubayashi, Nobuki
    Negishi, Takahito
    Sakamoto, Naotaka
    Tamura, Shingo
    Morokuma, Futoshi
    Song, Yoohyun
    Hori, Yoshifumi
    Tomoda, Toshihisa
    Seki, Narihito
    Kuroiwa, Kentaro
    Nakamura, Motonobu
    IN VIVO, 2021, 35 (05): : 2869 - 2874
  • [6] Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
    Minato, Akinori
    Ohno, Daichi
    Murooka, Kazuki
    Okumura, Yutaka
    Takaba, Tomohisa
    Higashijima, Katsuyoshi
    Nagata, Yujiro
    Tomisaki, Ikko
    Harada, Kenichi
    Fujimoto, Naohiro
    IN VIVO, 2024, 38 (04): : 1927 - 1934
  • [7] Outcomes by complete response to first-line pembrolizumab or platinum-based chemotherapy in advanced urothelial carcinoma (UC) in KEYNOTE-361
    Ozyilkan, Ozgur
    McDermott, Raymond S.
    Juan-Fita, Maria Jose
    Semenov, Andrey
    Alekseev, Boris
    Berger, Raanan
    Bae, Woo Kyun
    Danchaivijitr, Pongwut
    Lin, Jianxin
    Bavle, Abhishek Amar
    Imai, Kentaro
    Arslan, Cagatay
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] EFFICACY AND SAFETY OF FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH POST-OPERATIVE RECURRENCE AFTER PLATINUM-BASED ADJUVANT CHEMOTHERAPY
    Muraki, K.
    Imai, H.
    Shukuya, T.
    Ohhashi, R.
    Koyama, R.
    Mori, T.
    Murakami, H.
    Takahashi, T.
    Yamamoto, N.
    Takahashi, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 148 - 148
  • [9] FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma
    Ishizuya, Yu
    Kawashima, Atsunari
    Horibe, Yuki
    Yamamoto, Akinaru
    Tani, Masaru
    Yoshimura, Akihiro
    Yutong, Liu
    Nesrine, Sassi
    Oka, Toshiki
    Okuda, Yohei
    Uemura, Toshihiro
    Yamamichi, Gaku
    Hayashi, Takuji
    Yamamoto, Yoshiyuki
    Kato, Taigo
    Hatano, Koji
    Nonomura, Norio
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study
    Narita, Takuma
    Hatakeyama, Shingo
    Numakura, Kazuyuki
    Kobayashi, Mizuki
    Muto, Yumina
    Saito, Mitsuru
    Narita, Shintaro
    Tanaka, Toshikazu
    Noro, Daisuke
    Tokui, Noriko
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 899 - 905
12345